Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Leishmania RNA Virus Controls the Severity of Mucocutaneous Leishmaniasis
Annette Ives,1
Catherine Ronet,1
Florence Prevel,1
Giulia Ruzzante,1
Silvia Fuertes-Marraco,1
Frederic Schutz,2
Haroun Zangger,1
Melanie Revaz-Breton,1,*
Lon-Fye Lye,3
Suzanne M. Hickerson,3
Stephen M. Beverley,3
Hans Acha-Orbea,1
Pascal Launois,4
Nicolas Fasel,1,
Slavica Masina1
Abstract:
Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus–1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.
1 Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland. 2 Swiss Institute of Bioinformatics, University of Lausanne, 1015 Dorigny, Switzerland. 3 Department of Molecular Microbiology, Washington University, School of Medicine, St Louis, MO 63110, USA. 4 World Health Organization–Immunology Research and Training Centre, 1066 Epalinges, Switzerland.
* Present address: Route de Berne 7A, 1700 Fribourg, Switzerland.
To whom correspondence should be addressed. E-mail: nicolas.fasel{at}unil.ch
The editors suggest the following Related Resources on Science sites:
Role of Toll-Like Receptor 9 Signaling in Experimental Leishmania braziliensis Infection.
T. Weinkopff, A. Mariotto, G. Simon, Y. Hauyon-La Torre, F. Auderset, S. Schuster, H. Zangger, N. Fasel, A. Barral, and F. Tacchini-Cottier (2013)
Infect. Immun.
81, 1575-1584
|Abstract »|Full Text »|PDF »
Structure of a Protozoan Virus from the Human Genitourinary Parasite Trichomonas vaginalis.
K. N. Parent, Y. Takagi, G. Cardone, N. H. Olson, M. Ericsson, M. Yang, Y. Lee, J. M. Asara, R. N. Fichorova, T. S. Baker, et al. (2013)
mBio
4, e00056-13
|Abstract »|Full Text »|PDF »
UNC93B1 and Nucleic Acid-sensing Toll-like Receptors Mediate Host Resistance to Infection with Leishmania major.
B. L. F. Schamber-Reis, P. M. Petritus, B. C. Caetano, E. R. Martinez, K. Okuda, D. Golenbock, P. Scott, and R. T. Gazzinelli (2013)
J. Biol. Chem.
288, 7127-7136
|Abstract »|Full Text »|PDF »
Transmission and Epidemiology of Zoonotic Protozoal Diseases of Companion Animals.
Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2.
A. de Carvalho Vivarini, R. d. M. S. Pereira, K. L. Dias Teixeira, T. C. Calegari-Silva, M. Bellio, M. D. Laurenti, C. E. P. Corbett, C. M. de Castro Gomes, R. P. Soares, A. M. Silva, et al. (2011)
FASEB J
25, 4162-4173
|Abstract »|Full Text »|PDF »
Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples.
J. L. Weirather, S. M. B. Jeronimo, S. Gautam, S. Sundar, M. Kang, M. A. Kurtz, R. Haque, A. Schriefer, S. Talhari, E. M. Carvalho, et al. (2011)
J. Clin. Microbiol.
49, 3892-3904
|Abstract »|Full Text »|PDF »